ArticleBlood advances2022

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes.

Julia Stomper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.